E-LIB Suche - Ergebnisse für: Ullmann, Martin

1

Comparison of the efficacy and safety of a proposed biosimi..:

Zubrzycka-Sienkiewicz, Anna ; Klama, Kamilla ; Ullmann, Martin...
RMD Open. 10 (2024) 1 - p. e003596 , 2024

2

Pharmacokinetics of a proposed tocilizumab biosimilar (MSB1..:

Tomaszewska-Kiecana, Monika ; Ullmann, Martin ; Petit-Frere, Corinne...
Expert Review of Clinical Immunology. 19 (2023) 4 - p. 439-446 , 2023

Link: https://doi.org/10.1080/..

3

Pharmacokinetics and tolerability of prefilled syringe and ..:

Tomaszewska-Kiecana, Monika ; Dryja, Anna ; Ullmann, Martin...
Expert Review of Clinical Immunology. 19 (2023) 4 - p. 447-455 , 2023

Link: https://doi.org/10.1080/..

4

When to Extend Monitoring of Anti-drug Antibodies for High-..:

Lotz, Gregor P. ; Benstein, Karin ; Bloem, Karien...
The AAPS Journal. 24 (2022) 3 - p. , 2022

Link: https://doi.org/10.1208/..

5

Pharmacokinetics and pharmacodynamics of a proposed tociliz..:

Schwabe, Christian ; Illes, Andras ; Ullmann, Martin...
Expert Review of Clinical Immunology. 18 (2022) 5 - p. 533-543 , 2022

Link: https://doi.org/10.1080/..

6

Pharmacokinetics and Pharmacodynamics of a Proposed Pegfilg..:

Lickliter, Jason ; Kanceva, Radmila ; Vincent, Emmanuelle...
Clinical Therapeutics. 42 (2020) 8 - p. 1508-1518.e1 , 2020

Link: https://doi.org/10.1016/..

7

Immunogenicity and safety of a proposed pegfilgrastim biosi..:

Wynne, Chris ; Schwabe, Christian ; Vincent, Emmanuelle...
Pharmacology Research & Perspectives. 8 (2020) 2 - p. , 2020

Link: https://doi.org/10.1002/..

8

Safety of adalimumab biosimilar MSB11022 (acetate-buffered ..:

Edwards, Christopher J. ; Monnet, Joëlle ; Ullmann, Martin...
Clinical Rheumatology. 38 (2019) 12 - p. 3381-3390 , 2019

Link: https://doi.org/10.1007/..

9

Demonstrating Biosimilar and Originator Antidrug Antibody B..:

Ryding, Janka ; Stahl, Michael ; Ullmann, Martin
Bioanalysis. 9 (2017) 18 - p. 1395-1406 , 2017

Link: https://doi.org/10.4155/..

10

Comparison of the pharmacokinetics, safety, and immunogenic..:

Hyland, Elizabeth ; Mant, Tim ; Vlachos, Pantelis...
British Journal of Clinical Pharmacology. 82 (2016) 4 - p. 983-993 , 2016

Link: https://doi.org/10.1111/..

11

Application of proper orthogonal decomposition methods in r..:

Ullmann, Martin ; Prüfert, Uwe ; Seidel, Jens..
The Canadian Journal of Chemical Engineering. 92 (2014) 9 - p. 1552-1560 , 2014

Link: https://doi.org/10.1002/..

12

Bioanalytical Method Validation for Macromolecules in Suppo..:

Smolec, JoMarie ; DeSilva, Binodh ; Smith, Wendell...
Pharmaceutical Research. 22 (2005) 9 - p. 1425-1431 , 2005

Link: https://doi.org/10.1007/..

13

Porušování a ochrana výsad a imunit diplomatických misí a k..:

Ullmann, Martin
http://hdl.handle.net/20.500.11956/172465. , 2022

Link: https://hdl.handle.net/2..

14

Immunogenicity and safety of a proposed pegfilgrastim biosi..:

Wynne, Chris ; Schwabe, Christian ; Vincent, Emmanuelle...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183238/. , 2020

Link: http://www.ncbi.nlm.nih...

15

Comparison of the pharmacokinetics, safety, and immunogenic..:

Hyland, Elizabeth ; Mant, Tim ; Vlachos, Pantelis...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137823/. , 2016

Link: http://www.ncbi.nlm.nih...